NASDAQ:MTEX - Nasdaq - US5637712036 - Common Stock - Currency: USD
NASDAQ:MTEX (6/27/2025, 11:59:26 AM)
10.16
+0.71 (+7.51%)
The current stock price of MTEX is 10.16 USD. In the past month the price decreased by -0.53%. In the past year, price increased by 39.18%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 22.33 | 149.43B | ||
KVUE | KENVUE INC | 19.13 | 40.39B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 39.57 | 29.18B | ||
BRBR | BELLRING BRANDS INC | 26.99 | 7.40B | ||
ELF | ELF BEAUTY INC | 36.64 | 7.00B | ||
IPAR | INTERPARFUMS INC | 25.27 | 4.28B | ||
ODD | ODDITY TECH LTD-CL A | 37.16 | 4.21B | ||
COTY | COTY INC-CL A | 19.23 | 4.03B | ||
EPC | EDGEWELL PERSONAL CARE CO | 8.22 | 1.11B | ||
OLPX | OLAPLEX HOLDINGS INC | 19.75 | 1.05B | ||
YSG | YATSEN HOLDING LTD-ADR | N/A | 1.01B | ||
HLF | HERBALIFE LTD | 4.11 | 862.67M |
Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. The company is headquartered in Flower Mound, Texas and currently employs 189 full-time employees. The firm develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The firm's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.
MANNATECH INC
1410 Lakeside Parkway, Suite 200
Flower Mound TEXAS 75028 US
CEO: Alfredo Bala
Employees: 189
Phone: 19724717400
The current stock price of MTEX is 10.16 USD. The price increased by 7.51% in the last trading session.
The exchange symbol of MANNATECH INC is MTEX and it is listed on the Nasdaq exchange.
MTEX stock is listed on the Nasdaq exchange.
MANNATECH INC (MTEX) has a market capitalization of 19.30M USD. This makes MTEX a Nano Cap stock.
MANNATECH INC (MTEX) currently has 189 employees.
MANNATECH INC (MTEX) has a support level at 8.9 and a resistance level at 9.81. Check the full technical report for a detailed analysis of MTEX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MANNATECH INC (MTEX) has a dividend yield of 8.83%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of MTEX dividend history, reliability and sustainability.
MANNATECH INC (MTEX) will report earnings on 2025-08-11.
MANNATECH INC (MTEX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).
The outstanding short interest for MANNATECH INC (MTEX) is 0.61% of its float. Check the ownership tab for more information on the MTEX short interest.
ChartMill assigns a technical rating of 4 / 10 to MTEX. When comparing the yearly performance of all stocks, MTEX is one of the better performing stocks in the market, outperforming 85.18% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to MTEX. MTEX has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months MTEX reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 87.77% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.6% | ||
ROE | -2.9% | ||
Debt/Equity | 0.46 |